Tandem Diabetes Care (0M0F) Income Statement
Tandem Diabetes Care Income Statement
Last quarter (Q2 2026), Tandem Diabetes Care's total revenue was $254.56M, an increase of 5.77% from the same quarter last year. In Q2, Tandem Diabetes Care's net income was $-21.17M. See Tandem Diabetes Care’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.01B | $ 940.20M | $ 747.72M | $ 801.22M | $ 702.80M | |
| $ 530.85M | $ 489.57M | $ 367.69M | $ 412.99M | $ 376.21M | |
| $ 608.97M | $ 588.70M | $ 600.92M | $ 505.83M | $ 353.56M | |
| Depreciation and Amortization | $ 17.67M | $ 16.61M | $ 15.71M | $ 14.33M | $ 13.85M |
| $ -174.70M | $ -82.68M | $ -196.46M | $ -74.21M | $ 34.06M | |
| $ -78.12M | $ -99.13M | $ -233.23M | $ -92.85M | $ 22.65M | |
| $ -122.15M | $ 7.26M | $ 12.98M | $ -4.00K | $ -6.75M | |
| $ -200.27M | $ -91.87M | $ -220.25M | $ -92.85M | $ 15.90M | |
| $ -204.71M | $ -96.03M | $ -222.61M | $ -94.59M | $ 15.57M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.04 | $ -1.47 | $ -3.43 | $ -1.47 | $ 0.25 |
| Diluted EPS | $ -3.04 | $ -1.47 | $ -3.43 | $ -1.47 | $ 0.24 |
| Weighted Average Shares Outstanding | 67.28M | 65.45M | 64.90M | 64.15M | 63.00M |
| Weighted Average Shares Outstanding (Diluted) | 67.28M | 65.45M | 64.97M | 64.15M | 64.35M |
Currency in USD